Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Context Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder as a result of mutation in genes encoding either the ACTH receptor [melanocortin 2 receptor (MC2R)] or its accessory protein [melanocortin 2 receptor accessory protein (MRAP)]. The disorder is known as FGD type 1 and 2, respectively. Objective The aim of the study was to compare the phenotype/genotype relationships between FGD 1 and 2. Design and patients Forty patients with missense MC2R mutations and 22 patients with MRAP mutations were included. Forty‐four of these patients had been referred for genetic screening and 18 were patients published by other authors. Results The median age at presentation for FGD type 1 was variable at 2·0 years; range 0·02–16 years, and this was associated with unusually tall stature, mean height SDS + 1·75 ± 1·53 (mean ± SD). In contrast, FGD type 2 presented at a much earlier median age (0·08 years; range at birth to 1·6 years) (P < 0·01) and patients were of normal height SDS + 0·12 ± 1·35 (P < 0·001). No differences in baseline cortisol or ACTH levels were seen between FGD types 1 and 2. Conclusion FGD type 2 appears to present earlier. This may reflect the functional significance of the underlying mutations in that all MRAP mutations are nonsense or splice site mutations that result in abolition of a functional protein, whereas most of the MC2R mutations are missense mutations and give rise to proteins with some residual function. Tall stature is associated with mutations in MC2R but not in MRAP. There were no other significant clinical distinctions between the two.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437
Self-citationAdrenocorticotropin insensitivity syndromes
Clark, A. J. L., & Weber, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0351 · Cited by 234
Self-citationTsigos, C., Arai, K., Hung, W., & Chrousos, G. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116853 · Cited by 182
Chung, T. T., Webb, T. R., Chan, L. F., Cooray, S. N., Metherell, L. A., King, P. J., Chapple, J. P., & Clark, A. J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1744 · Cited by 82
Inherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Self-citationFlück, C. E., Martens, J. W. M., Conte, F. A., & Miller, W. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020501 · Cited by 57
Cited by
Guran, T., Buonocore, F., Saka, N., Ozbek, M. N., Aycan, Z., Bereket, A., Bas, F., Darcan, S., Bideci, A., Guven, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3250 · Cited by 207
The melanocortin receptors and their accessory proteins
Ramachandrappa, S., Gorrigan, R. J., Clark, A. J. L., & Chan, L. F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00009 · Cited by 87
“However, patients with MRAP mutations present with isolated glucocorticoid deficiency apparently without any other additional symptoms (Chung et al., 2010).”
BackgroundSelf-citationCooray, S. N., Chung, T.-T., Mazhar, K., Szidonya, L., & Clark, A. J. L. (2011) · Endocrinology · doi:10.1210/en.2010-1053 · Cited by 33
“ACTH insensitivity (6, 7), and knockdown of MRAP in an adrenocortical cell line reduces ACTH responsiveness (8).”
Background
Metadata
- Authors
- Chung, T. L. L., Chan, L. F., Metherell, L. A., & Clark, A. J. L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2010-03-25
- Volume
- 72
- Issue
- 5
- Pages
- 589-594
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1971824221
- Cited by
- 92
- References
- 6
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. https://app.cochat.ai/papers/10.1111/j.1365-2265.2009.03663.x
- The paper
- Chung, T. L. L., Chan, L. F., Metherell, L. A., & Clark, A. J. L. (2010). Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2009.03663.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.